#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer Synovial sarcoma recurrent Amyotrophic lateral sclerosis Uveal melanoma Waldenstrom's macroglobulinaemia Endocrine ophthalmopathy Chronic myeloid leukaemia (in remission) Uveitis Arginase deficiency Craniocerebral injury Acute graft versus host disease in liver Infertility female Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Bronchopulmonary aspergillosis Medulloblastoma More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Diagnostics Marginal zone lymphoma refractory – Trials in Disease Lymphangioma – Basic Information Phenylketonuria Langerhans cell sarcoma – Basic Information Indolent systemic mastocytosis – Life with Disease Krabbe’s disease – Trials in Disease Haemophilia A without inhibitors – Trials in Disease Piriformis syndrome – Basic Information Systemic sclerosis pulmonary – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taplucainium Chloride PETHIDINE HYDROCHLORIDE Vilobelimab Gns561 VOTOPLAM MARALIXIBAT Dexrazoxane Sodium Sulfate Anhydrous Ciltacabtagene Autoleucel LTI-03 ICOTROKINRA Patritumab Deruxtecan Rigosertib Sodium Rbd4059 Haloperidol Idarubicin Ptg-Carcik-Cd19 GSKVX000000034794 Timrepigene Emparvovec Azd3470 More therapies…

    Learn about Your Condition

    Epidermolysis bullosa Cervix carcinoma stage IV Alcohol use disorder Obsessive-compulsive disorder Pulmonary resection Infertility Ankylosing spondylitis Vestibular disorder Petit mal epilepsy Endometrial cancer metastatic MELAS syndrome Syphilis Endocarditis bacterial Shprintzen-Goldberg syndrome Somatic symptom disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Specialized Eye Diseases Hospital For Active Treatment-Varna…

Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD

Ulitsa Doyran 15, Varna, 9002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Upacicalcet Sodium Hydrate
    Bulgaria Poland Portugal Spain

  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Aflibercept
    Belgium Bulgaria Czechia Greece Italy Portugal +4

  • Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Retinal vein occlusion
    Investigated Drugs:
    • Fluorescein Sodium
    • Aflibercept
    Austria Bulgaria Czechia Estonia France Germany +8
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!